Peripheral blood cytokine responses and disease severity in respiratory syncytial virus bronchiolitis

The role of cellular immunity in disease severity in respiratory syncytial virus (RSV) bronchiolitis is largely unknown. This study investigated the association between disease severity and systemic cytokine responses in hospitalized ventilated and nonventilated RSV bronchiolitis patients. In whole...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The European respiratory journal 1999-07, Vol.14 (1), p.144-149
Hauptverfasser: Bont, L, Heijnen, CJ, Kavelaars, A, van Aalderen, WM, Brus, F, Draaisma, JT, Geelen, SM, van Vught, HJ, Kimpen, JL
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 149
container_issue 1
container_start_page 144
container_title The European respiratory journal
container_volume 14
creator Bont, L
Heijnen, CJ
Kavelaars, A
van Aalderen, WM
Brus, F
Draaisma, JT
Geelen, SM
van Vught, HJ
Kimpen, JL
description The role of cellular immunity in disease severity in respiratory syncytial virus (RSV) bronchiolitis is largely unknown. This study investigated the association between disease severity and systemic cytokine responses in hospitalized ventilated and nonventilated RSV bronchiolitis patients. In whole blood cultures stimulated with phytohaemagglutinin (PHA), lymphoproliferative responses and interferon (IFN)‐γ and interleukin (IL)‐4 production during acute illness were measured. In addition, plasma cytokines were measured. Measurements were repeated in the convalescent phase, 3–4 weeks after admission. Fifty patients were included. The median age in ventilaled patients was significantly lower than in nonventilated patients (1 versus 4 months, p
doi_str_mv 10.1034/j.1399-3003.1999.14a24.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70045667</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70045667</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4754-19853ce2f41ce961fd2cd6da9e58d404ae5ee0d1145ecfb2a2579b6cc111b7033</originalsourceid><addsrcrecordid>eNqNkEtv1DAUhS0EokPhLyAvoLsJvrHz8AapqspLlUAI1pbj3DAePPHgO9M2_x6nGQFLVl74O-cefYxxEAUIqd5sC5Bar6UQsgCtdQHKlqq4f8RWfz4es5XQQq5By_qMPSPaCgG1kvCUnYFQrW5VuWL4BZPfbzDZwLsQY8_ddIg__Yg8Ie3jSEjcjj3vPaEl5IS3OXGYuB8fCJ_sIaaJ0zTmpM81tz4diXcpjm7jY_AHT8_Zk8EGwhen95x9f3f97erD-ubz-49Xlzdrp5pK5altJR2WgwKHuoahL11f91Zj1fZKKIsVougBVIVu6EpbVo3uaucAoGuElOfsYundp_jriHQwO08OQ7AjxiOZRghV1XWTwXYBXYpECQezT35n02RAmFmx2ZrZpJlNmlmxeVBs7nP05enGsdth_09wcZqBVyfAkrNhSHZ0nv5yutRNOW99u2B3PuD03_fN9ddPoC5LlQteLwUb_2Nz5xMa2tkQ8iwwmLagDOSQkr8Bx4Snog</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70045667</pqid></control><display><type>article</type><title>Peripheral blood cytokine responses and disease severity in respiratory syncytial virus bronchiolitis</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Access via Wiley Online Library</source><creator>Bont, L ; Heijnen, CJ ; Kavelaars, A ; van Aalderen, WM ; Brus, F ; Draaisma, JT ; Geelen, SM ; van Vught, HJ ; Kimpen, JL</creator><creatorcontrib>Bont, L ; Heijnen, CJ ; Kavelaars, A ; van Aalderen, WM ; Brus, F ; Draaisma, JT ; Geelen, SM ; van Vught, HJ ; Kimpen, JL</creatorcontrib><description>The role of cellular immunity in disease severity in respiratory syncytial virus (RSV) bronchiolitis is largely unknown. This study investigated the association between disease severity and systemic cytokine responses in hospitalized ventilated and nonventilated RSV bronchiolitis patients. In whole blood cultures stimulated with phytohaemagglutinin (PHA), lymphoproliferative responses and interferon (IFN)‐γ and interleukin (IL)‐4 production during acute illness were measured. In addition, plasma cytokines were measured. Measurements were repeated in the convalescent phase, 3–4 weeks after admission. Fifty patients were included. The median age in ventilaled patients was significantly lower than in nonventilated patients (1 versus 4 months, p&lt;0.05). In comparison with nonventilated patients, the ventilated patients had significantly lower lymphoproliferative responses and a lower production of IFN‐γ and IL‐4. In fact, IFN‐γ and IL‐4 production in ventilated patients was almost completely undetectable. Plasma IL‐8 levels in ventilated patients were significantly higher than in nonventilated patients. In the convalescent phase, lymphoproliferative and cytokine responses as well as plasma IL‐8 levels were normal in both patient groups. Since RSV bronchiolitis is associated with the subsequent development of asthma, the possible skewing of the T‐helper (Th1/Th2) cytokine balance was investigated. This was found neither in the acute nor in the convalescent phase. In conclusion, the data indicate that depressed lymphocyte function and elevated plasma interleukin‐8 levels are markers of severe disease. It is suggested that age and maturation related immune mechanisms could explain the occurrence of severe respiratory syncytial virus bronchiolitis requiring mechanical ventilation in young infants.</description><identifier>ISSN: 0903-1936</identifier><identifier>EISSN: 1399-3003</identifier><identifier>DOI: 10.1034/j.1399-3003.1999.14a24.x</identifier><identifier>PMID: 10489842</identifier><language>eng</language><publisher>Oxford, UK: Eur Respiratory Soc</publisher><subject>AIDS/HIV ; Antibodies, Viral - analysis ; Biological and medical sciences ; Biomarkers - blood ; Bronchiolitis, Viral - blood ; Bronchiolitis, Viral - immunology ; Bronchiolitis, Viral - virology ; Cells, Cultured ; Cytokines ; disease severity ; Female ; Human viral diseases ; Humans ; Infant ; Infant, Newborn ; Infectious diseases ; Interferon-gamma - blood ; Interleukin-12 - blood ; Interleukin-4 - blood ; Interleukin-8 - blood ; Male ; Medical sciences ; Phytohemagglutinins ; respiratory syncytial virus ; Respiratory Syncytial Virus Infections - blood ; Respiratory Syncytial Virus Infections - immunology ; Respiratory Syncytial Virus Infections - virology ; Respiratory Syncytial Viruses - immunology ; Respiratory Syncytial Viruses - isolation &amp; purification ; Severity of Illness Index ; Th1 Cells - drug effects ; Th1 Cells - metabolism ; Th1 Cells - pathology ; Th2 Cells - drug effects ; Th2 Cells - metabolism ; Th2 Cells - pathology ; Viral diseases ; Viral diseases of the respiratory system and ent viral diseases</subject><ispartof>The European respiratory journal, 1999-07, Vol.14 (1), p.144-149</ispartof><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4754-19853ce2f41ce961fd2cd6da9e58d404ae5ee0d1145ecfb2a2579b6cc111b7033</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1034%2Fj.1399-3003.1999.14a24.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,782,786,1419,27933,27934,45584</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1929723$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10489842$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bont, L</creatorcontrib><creatorcontrib>Heijnen, CJ</creatorcontrib><creatorcontrib>Kavelaars, A</creatorcontrib><creatorcontrib>van Aalderen, WM</creatorcontrib><creatorcontrib>Brus, F</creatorcontrib><creatorcontrib>Draaisma, JT</creatorcontrib><creatorcontrib>Geelen, SM</creatorcontrib><creatorcontrib>van Vught, HJ</creatorcontrib><creatorcontrib>Kimpen, JL</creatorcontrib><title>Peripheral blood cytokine responses and disease severity in respiratory syncytial virus bronchiolitis</title><title>The European respiratory journal</title><addtitle>Eur Respir J</addtitle><description>The role of cellular immunity in disease severity in respiratory syncytial virus (RSV) bronchiolitis is largely unknown. This study investigated the association between disease severity and systemic cytokine responses in hospitalized ventilated and nonventilated RSV bronchiolitis patients. In whole blood cultures stimulated with phytohaemagglutinin (PHA), lymphoproliferative responses and interferon (IFN)‐γ and interleukin (IL)‐4 production during acute illness were measured. In addition, plasma cytokines were measured. Measurements were repeated in the convalescent phase, 3–4 weeks after admission. Fifty patients were included. The median age in ventilaled patients was significantly lower than in nonventilated patients (1 versus 4 months, p&lt;0.05). In comparison with nonventilated patients, the ventilated patients had significantly lower lymphoproliferative responses and a lower production of IFN‐γ and IL‐4. In fact, IFN‐γ and IL‐4 production in ventilated patients was almost completely undetectable. Plasma IL‐8 levels in ventilated patients were significantly higher than in nonventilated patients. In the convalescent phase, lymphoproliferative and cytokine responses as well as plasma IL‐8 levels were normal in both patient groups. Since RSV bronchiolitis is associated with the subsequent development of asthma, the possible skewing of the T‐helper (Th1/Th2) cytokine balance was investigated. This was found neither in the acute nor in the convalescent phase. In conclusion, the data indicate that depressed lymphocyte function and elevated plasma interleukin‐8 levels are markers of severe disease. It is suggested that age and maturation related immune mechanisms could explain the occurrence of severe respiratory syncytial virus bronchiolitis requiring mechanical ventilation in young infants.</description><subject>AIDS/HIV</subject><subject>Antibodies, Viral - analysis</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - blood</subject><subject>Bronchiolitis, Viral - blood</subject><subject>Bronchiolitis, Viral - immunology</subject><subject>Bronchiolitis, Viral - virology</subject><subject>Cells, Cultured</subject><subject>Cytokines</subject><subject>disease severity</subject><subject>Female</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Infectious diseases</subject><subject>Interferon-gamma - blood</subject><subject>Interleukin-12 - blood</subject><subject>Interleukin-4 - blood</subject><subject>Interleukin-8 - blood</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Phytohemagglutinins</subject><subject>respiratory syncytial virus</subject><subject>Respiratory Syncytial Virus Infections - blood</subject><subject>Respiratory Syncytial Virus Infections - immunology</subject><subject>Respiratory Syncytial Virus Infections - virology</subject><subject>Respiratory Syncytial Viruses - immunology</subject><subject>Respiratory Syncytial Viruses - isolation &amp; purification</subject><subject>Severity of Illness Index</subject><subject>Th1 Cells - drug effects</subject><subject>Th1 Cells - metabolism</subject><subject>Th1 Cells - pathology</subject><subject>Th2 Cells - drug effects</subject><subject>Th2 Cells - metabolism</subject><subject>Th2 Cells - pathology</subject><subject>Viral diseases</subject><subject>Viral diseases of the respiratory system and ent viral diseases</subject><issn>0903-1936</issn><issn>1399-3003</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkEtv1DAUhS0EokPhLyAvoLsJvrHz8AapqspLlUAI1pbj3DAePPHgO9M2_x6nGQFLVl74O-cefYxxEAUIqd5sC5Bar6UQsgCtdQHKlqq4f8RWfz4es5XQQq5By_qMPSPaCgG1kvCUnYFQrW5VuWL4BZPfbzDZwLsQY8_ddIg__Yg8Ie3jSEjcjj3vPaEl5IS3OXGYuB8fCJ_sIaaJ0zTmpM81tz4diXcpjm7jY_AHT8_Zk8EGwhen95x9f3f97erD-ubz-49Xlzdrp5pK5altJR2WgwKHuoahL11f91Zj1fZKKIsVougBVIVu6EpbVo3uaucAoGuElOfsYundp_jriHQwO08OQ7AjxiOZRghV1XWTwXYBXYpECQezT35n02RAmFmx2ZrZpJlNmlmxeVBs7nP05enGsdth_09wcZqBVyfAkrNhSHZ0nv5yutRNOW99u2B3PuD03_fN9ddPoC5LlQteLwUb_2Nz5xMa2tkQ8iwwmLagDOSQkr8Bx4Snog</recordid><startdate>199907</startdate><enddate>199907</enddate><creator>Bont, L</creator><creator>Heijnen, CJ</creator><creator>Kavelaars, A</creator><creator>van Aalderen, WM</creator><creator>Brus, F</creator><creator>Draaisma, JT</creator><creator>Geelen, SM</creator><creator>van Vught, HJ</creator><creator>Kimpen, JL</creator><general>Eur Respiratory Soc</general><general>European Respiratory Journal</general><general>Maney</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199907</creationdate><title>Peripheral blood cytokine responses and disease severity in respiratory syncytial virus bronchiolitis</title><author>Bont, L ; Heijnen, CJ ; Kavelaars, A ; van Aalderen, WM ; Brus, F ; Draaisma, JT ; Geelen, SM ; van Vught, HJ ; Kimpen, JL</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4754-19853ce2f41ce961fd2cd6da9e58d404ae5ee0d1145ecfb2a2579b6cc111b7033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>AIDS/HIV</topic><topic>Antibodies, Viral - analysis</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - blood</topic><topic>Bronchiolitis, Viral - blood</topic><topic>Bronchiolitis, Viral - immunology</topic><topic>Bronchiolitis, Viral - virology</topic><topic>Cells, Cultured</topic><topic>Cytokines</topic><topic>disease severity</topic><topic>Female</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Infectious diseases</topic><topic>Interferon-gamma - blood</topic><topic>Interleukin-12 - blood</topic><topic>Interleukin-4 - blood</topic><topic>Interleukin-8 - blood</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Phytohemagglutinins</topic><topic>respiratory syncytial virus</topic><topic>Respiratory Syncytial Virus Infections - blood</topic><topic>Respiratory Syncytial Virus Infections - immunology</topic><topic>Respiratory Syncytial Virus Infections - virology</topic><topic>Respiratory Syncytial Viruses - immunology</topic><topic>Respiratory Syncytial Viruses - isolation &amp; purification</topic><topic>Severity of Illness Index</topic><topic>Th1 Cells - drug effects</topic><topic>Th1 Cells - metabolism</topic><topic>Th1 Cells - pathology</topic><topic>Th2 Cells - drug effects</topic><topic>Th2 Cells - metabolism</topic><topic>Th2 Cells - pathology</topic><topic>Viral diseases</topic><topic>Viral diseases of the respiratory system and ent viral diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bont, L</creatorcontrib><creatorcontrib>Heijnen, CJ</creatorcontrib><creatorcontrib>Kavelaars, A</creatorcontrib><creatorcontrib>van Aalderen, WM</creatorcontrib><creatorcontrib>Brus, F</creatorcontrib><creatorcontrib>Draaisma, JT</creatorcontrib><creatorcontrib>Geelen, SM</creatorcontrib><creatorcontrib>van Vught, HJ</creatorcontrib><creatorcontrib>Kimpen, JL</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The European respiratory journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bont, L</au><au>Heijnen, CJ</au><au>Kavelaars, A</au><au>van Aalderen, WM</au><au>Brus, F</au><au>Draaisma, JT</au><au>Geelen, SM</au><au>van Vught, HJ</au><au>Kimpen, JL</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Peripheral blood cytokine responses and disease severity in respiratory syncytial virus bronchiolitis</atitle><jtitle>The European respiratory journal</jtitle><addtitle>Eur Respir J</addtitle><date>1999-07</date><risdate>1999</risdate><volume>14</volume><issue>1</issue><spage>144</spage><epage>149</epage><pages>144-149</pages><issn>0903-1936</issn><eissn>1399-3003</eissn><abstract>The role of cellular immunity in disease severity in respiratory syncytial virus (RSV) bronchiolitis is largely unknown. This study investigated the association between disease severity and systemic cytokine responses in hospitalized ventilated and nonventilated RSV bronchiolitis patients. In whole blood cultures stimulated with phytohaemagglutinin (PHA), lymphoproliferative responses and interferon (IFN)‐γ and interleukin (IL)‐4 production during acute illness were measured. In addition, plasma cytokines were measured. Measurements were repeated in the convalescent phase, 3–4 weeks after admission. Fifty patients were included. The median age in ventilaled patients was significantly lower than in nonventilated patients (1 versus 4 months, p&lt;0.05). In comparison with nonventilated patients, the ventilated patients had significantly lower lymphoproliferative responses and a lower production of IFN‐γ and IL‐4. In fact, IFN‐γ and IL‐4 production in ventilated patients was almost completely undetectable. Plasma IL‐8 levels in ventilated patients were significantly higher than in nonventilated patients. In the convalescent phase, lymphoproliferative and cytokine responses as well as plasma IL‐8 levels were normal in both patient groups. Since RSV bronchiolitis is associated with the subsequent development of asthma, the possible skewing of the T‐helper (Th1/Th2) cytokine balance was investigated. This was found neither in the acute nor in the convalescent phase. In conclusion, the data indicate that depressed lymphocyte function and elevated plasma interleukin‐8 levels are markers of severe disease. It is suggested that age and maturation related immune mechanisms could explain the occurrence of severe respiratory syncytial virus bronchiolitis requiring mechanical ventilation in young infants.</abstract><cop>Oxford, UK</cop><pub>Eur Respiratory Soc</pub><pmid>10489842</pmid><doi>10.1034/j.1399-3003.1999.14a24.x</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0903-1936
ispartof The European respiratory journal, 1999-07, Vol.14 (1), p.144-149
issn 0903-1936
1399-3003
language eng
recordid cdi_proquest_miscellaneous_70045667
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Access via Wiley Online Library
subjects AIDS/HIV
Antibodies, Viral - analysis
Biological and medical sciences
Biomarkers - blood
Bronchiolitis, Viral - blood
Bronchiolitis, Viral - immunology
Bronchiolitis, Viral - virology
Cells, Cultured
Cytokines
disease severity
Female
Human viral diseases
Humans
Infant
Infant, Newborn
Infectious diseases
Interferon-gamma - blood
Interleukin-12 - blood
Interleukin-4 - blood
Interleukin-8 - blood
Male
Medical sciences
Phytohemagglutinins
respiratory syncytial virus
Respiratory Syncytial Virus Infections - blood
Respiratory Syncytial Virus Infections - immunology
Respiratory Syncytial Virus Infections - virology
Respiratory Syncytial Viruses - immunology
Respiratory Syncytial Viruses - isolation & purification
Severity of Illness Index
Th1 Cells - drug effects
Th1 Cells - metabolism
Th1 Cells - pathology
Th2 Cells - drug effects
Th2 Cells - metabolism
Th2 Cells - pathology
Viral diseases
Viral diseases of the respiratory system and ent viral diseases
title Peripheral blood cytokine responses and disease severity in respiratory syncytial virus bronchiolitis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-03T02%3A06%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Peripheral%20blood%20cytokine%20responses%20and%20disease%20severity%20in%20respiratory%20syncytial%20virus%20bronchiolitis&rft.jtitle=The%20European%20respiratory%20journal&rft.au=Bont,%20L&rft.date=1999-07&rft.volume=14&rft.issue=1&rft.spage=144&rft.epage=149&rft.pages=144-149&rft.issn=0903-1936&rft.eissn=1399-3003&rft_id=info:doi/10.1034/j.1399-3003.1999.14a24.x&rft_dat=%3Cproquest_cross%3E70045667%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70045667&rft_id=info:pmid/10489842&rfr_iscdi=true